Grandeur Peak Global Advisors, LLC Adaptive Biotechnologies Corp Transaction History

Grandeur Peak Global Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$24.95 - $48.38 $269,460 - $522,504	-10,800 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$30.31 - $53.51 $294,007 - $519,047	-9,700 Reduced 47.32%	10,800 $334,000
Q2 2019 Aug 13, 2019	BUY	$40.3 - $48.3 $826,149 - $990,149	20,500 New	20,500 $990,000

201

146M

2.6K

143K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $516M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Grandeur Peak Global Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Grandeur Peak Global Advisors, LLC with notifications on news.